Back Pain News and Research RSS Feed - Back Pain News and Research

Back pain is a very common problem affecting almost all individuals at some point in their lives. Back pain most commonly affects the lower back although it can be felt anywhere along the spine. An individual may experience aching, tension and stiffness that lasts for only a few days or weeks, or these symptoms may continue for many months or even years.

In most cases, back pain does not have a specific or serious cause and is often referred to as 'non-specific' pain. However, the pain can be triggered or worsened by, for example, a poor sitting or standing posture or bending or lifting incorrectly.

The use of painkillers and keeping active is often sufficient for the condition to resolve within 12 weeks. If back pain lasts longer than this, in which case it is termed chronic pain, an individual should visit their doctor. If the back pain is accompanied by any one of a fever, unexplained weight loss, swelling in the back, chest pain, leg pain, loss of bladder or bowel control, inability to pass urine, or pain that is worse at night, then medical help should be sought immediately. These are termed 'red flag symptoms' and could be a sign of something more serious such as rheumatoid arthritis, a slipped disc or osteoporosis.

People can reduce their chance of developing back pain by engaging in regular exercise, particularly swimming or walking, taking care to bend from the knees and hips rather than the back and maintaining a good posture.
Better self-care and patient education can improve treatment for chronic pain

Better self-care and patient education can improve treatment for chronic pain

The National Pain Strategy, released this year by the U.S. Department of Health and Human Services, places strong emphasis on self management and patient education as critical pathways for improving treatment of chronic pain, especially the leading malady, back pain. [More]
Strength training lowers odds of death in older adults

Strength training lowers odds of death in older adults

Older adults who met twice-weekly strength training guidelines had lower odds of dying in a new analysis by researchers at Penn State College of Medicine, Penn State Health Milton S. Hershey Medical Center and Columbia University. The study is the first to demonstrate the association in a large, nationally representative sample over an extended time period, particularly in an older population. [More]
Professor outlines effects of sports-specific counseling on injury outcomes in youth athletes

Professor outlines effects of sports-specific counseling on injury outcomes in youth athletes

Neeru Jayanthi, MD, Associate Professor of Orthopedics and Sports Medicine at Emory University Sports Medicine Center in Atlanta, GA, presented "The Effects of Serial Sports Training Risk Assessment and Counseling in Kids (T.R.A.C.K.)" at the 25th Annual Meeting of the American Medical Society for Sports Medicine in Dallas, TX. [More]
Study to test effectiveness of worksite exercise regimen to reduce low back injury risk in firefighters

Study to test effectiveness of worksite exercise regimen to reduce low back injury risk in firefighters

The University of South Florida and Tampa Fire Rescue have launched a randomized controlled trial to assess the effectiveness of a worksite exercise regimen targeted to reduce the risk of low back injury and disability in firefighters -- a physically demanding occupation particularly prone to back problems that can lead to chronic pain and early retirement. [More]
European Medicines Agency approves first-ever treatment for hereditary factor X deficiency

European Medicines Agency approves first-ever treatment for hereditary factor X deficiency

Bio Products Laboratory, Limited (BPL) today announced that the European Medicines Agency has granted marketing authorisation for Coagadex. [More]
Restrictions to opioid prescription block their use for safe, effective pain relief

Restrictions to opioid prescription block their use for safe, effective pain relief

Opioids are very effective for treating some types of pain, such as cancer pain and postoperative pain, but not for other kinds of pain like chronic low back pain. An increase in the number of opioid-related deaths among addicts has led to the current movement to restrict opioid prescribing by state and federal authorities. [More]
New reference guide can help HIV care providers treat chronic pain

New reference guide can help HIV care providers treat chronic pain

Recent studies suggest many individuals with HIV have chronic pain. Estimates range from 39 percent all the way to 85 percent. Chronic pain is an important comorbid condition in individuals with HIV, as it is common and causes substantial disability. [More]
Sitting for all or much of the day could affect a person’s overall health

Sitting for all or much of the day could affect a person’s overall health

Despite their popularity, the effectiveness of stand-up desks and other strategies aimed at getting people to sit less at work is largely uncertain, according to a systematic review of published research conducted by Cochrane Collaboration authors [More]
IUPUI researchers examine pain experience, pain management among Hispanic Americans

IUPUI researchers examine pain experience, pain management among Hispanic Americans

Hispanic Americans report fewer pain conditions compared with non-Hispanic white or black Americans, according to a critical review and analysis of more than 100 studies on pain experience and pain management among Hispanic Americans. [More]
New study shows that structural changes within the spine alter vibration response

New study shows that structural changes within the spine alter vibration response

Magnetic resonance image isn't everything. A new University of Alberta study shows that vibrating the spine may reveal more when it comes to treating back pain. Teaming with the University of South Denmark to study the lumbar spine of twins, Greg Kawchuk and his team demonstrate that structural changes within the spine alter its vibration response significantly. [More]
Neck pain more common in women than in men, Loyola study finds

Neck pain more common in women than in men, Loyola study finds

Women are 1.38 times more likely than men to report neck pain due to cervical degenerative disc disease, according to a study of adult patients treated at Loyola Medicine's Pain Management Center. [More]
Report: One in two Americans affected by musculoskeletal condition

Report: One in two Americans affected by musculoskeletal condition

An estimated 126.6 million Americans (one in two adults) are affected by a musculoskeletal condition--comparable to the total percentage of Americans living with a chronic lung or heart condition--costing an estimated $213 billion in annual treatment, care and lost wages, according to a new report issued today by the United States Bone and Joint Initiative. [More]
Osteopathic manipulative treatment improves function in patients suffering from chronic low back pain

Osteopathic manipulative treatment improves function in patients suffering from chronic low back pain

Studies published in the Journal of the American Osteopathic Association found that osteopathic manipulative treatment (OMT) reduced pain and improved function in patients suffering from chronic, nonspecific low back pain. [More]
New review suggests solutions that can help ease chronic pain in women

New review suggests solutions that can help ease chronic pain in women

Women often suffer silently when in pain, whether it's caused by pregnancy discomfort or creaky knees. Yet there are a variety of solutions that can help relieve women of chronic pain, from exercise to identifying triggers, suggests a new review of research related to women and pain by the American Society of Anesthesiologists. [More]
Allergan receives FDA approval to market ACZONE (dapsone) Gel, 7.5% for acne treatment

Allergan receives FDA approval to market ACZONE (dapsone) Gel, 7.5% for acne treatment

Allergan plc, a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug Administration to market ACZONE (dapsone) Gel, 7.5%, a new prescription topical treatment for acne in patients 12 years of age and older. [More]
Black, white Americans cope with pain differently

Black, white Americans cope with pain differently

Researchers led by Adam T. Hirsh of the School of Science at Indiana University-Purdue University Indianapolis report that black and white Americans cope with pain differently and that blacks employ pain coping strategies more frequently than whites. The IUPUI review and analysis of 19 studies is the first to examine the entire published literature and quantify the relationship between race and the use of pain-coping strategies. [More]
Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Amgen and UCB today announced top-line results from the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME). [More]
Smoking linked to worsening degenerative disc disease in cervical spine

Smoking linked to worsening degenerative disc disease in cervical spine

Adding to the already length list of reasons not to smoke, researchers have connected smoking to worsening degenerative disc disease in the cervical spine, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif. [More]
New NYUCD study explores how gene expression initiated in notochord

New NYUCD study explores how gene expression initiated in notochord

A new study by basic science researchers in the Department of Basic Science and Craniofacial Biology at New York University College of Dentistry sought to understand how gene expression is initiated in the notochord, the evolutionary and developmental precursor of the backbone. [More]
Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

Astellas US LLC, a United States (U.S.) subsidiary of Tokyo-based Astellas Pharma Inc., and Medivation, Inc. today announced that results from the STRIVE trial of enzalutamide compared to bicalutamide in men with castration-resistant prostate cancer (CRPC) were published in the Journal of Clinical Oncology. [More]
Advertisement
Advertisement